The Gates Vascular Institute (GVI) is one of five medical facilities in the world to be selected to broadcast live surgeries at the Vascular Interventional Advances (VIVA) Conference, an educational and experiential forum for all specialties and stakeholders who touch the vascular patient utilizing cutting edge educational technology. The conference, which will be hosted in Las Vegas, NV, is a platform for world-renowned domestic and international VIVA faculty to challenge attendees and each other by analytically evaluating new, evolving therapies and innovations.
On Wednesday, September 13 at 5:15 p.m., the world-class neuro endovascular team at Kaleida Health and the University at Buffalo Neurosurgery, led by Elad Levy, MD, MBA, FACS, FAHA, and Adnan Siddiqui, MD, PhD, FACS, FAHA, will perform a live case from the GVI – a carotid intervention – to the 2,000 plus attendees. Dr. Siddiqui, in collaboration with David M. Zlotnick MD, FACC, FSCAI interventional cardiologist with UBMD Cardiovascular Medicine, will team up to perform a complex cerebral and upper extremity revascularization on Thursday, September 14, highlighting the power of two specialties working together at Kaleida Health’s Gates Vascular Institute to better serve the patient.
The GVI, renowned for its collaborative environment and method in treating vascular disease through multidisciplinary approaches, will be televising unique cases in conjunction with the Jacobs Institute (JI). The JI fosters medical collaboration and innovation through partnerships with the University at Buffalo (UB) and Kaleida Health.
"The University at Buffalo Neurosurgery, Kaleida Health's Gates Vascular Institute and the Jacobs Institute (JI) have been chosen as one of five international sites to transmit live cases from Buffalo to the world wide VIVA conference, showcasing Buffalo as a destination for world-class neuro vascular and cardiac care” said L. Nelson Hopkins, MD, FACS, founder and chief scientific officer of the Jacobs Institute. “Our participation in VIVA is a testimony to the outstanding reputation of our center for patient care, teaching and research.”
“We’re very proud to be performers at this tremendous event. This broadcast highlights the position we hold in the neuroendovascular world as leaders in bringing the latest and best technologies to the forefront,” said Dr. Siddiqui, director of neurosurgical stroke services for Kaleida Health, chief medical officer at the JI, vice chair and professor of neurosurgery at the Jacobs School of Medicine and Biomedical Sciences at UB. “We will showcase very complex cases using a range of innovative approaches to educate the global audience with an update in neuro and cardiac disease and minimally invasive intervention.” The GVI is able to broadcast cutting-edge cases to conferences around the globe, due to the JI’s unique broadcast capabilities.
Dr. Hopkins, founder of the GVI, will be receiving the ATLAS award on Tuesday, September 12 at the conference. The ATLAS award, which stands for a teacher, leader, and, scholar, celebrates the career and influence of physicians who have distinguished themselves as scholars and leaders in their respective vascular fields. The award recipients have dedicated their careers to advancing treatment of vascular disorders and teaching pioneering techniques to physicians all over the word to improve and expand patient care. Dr. Hopkins will be the 10th physician and only neurosurgeon in the world to receive the distinguished award.
VIVA, the largest peripheral vascular meeting in the world, showcases the most unprecedented research available in interventional medicine. A multidisciplinary, international, panel of experts in the field including: physicians, scientists and regulators, will ask questions and shed light on the lasting impact of the research results presented.
The Jacobs Institute is a non-profit organization whose mission is to accelerate the development of next-generation technologies in vascular medicine through collisions of physicians, engineers, entrepreneurs, and industry. The JI's vision is to improve the treatment of vascular disease in Western New York and the world, while fostering local economic development.